29th - 30th November 2018 | Frankfurt, Germany
Improving the treatment quality and clinical outcomes of cancer patients, and reducing the morbidity associated with oncological conditions and their treatment has been identified as an underscored need by the increasing number of cancer diagnoses that comes with an aging population. Nanobiotics has already shown much promise in improving the management of cancer. Increasing the sensitivity of cancer imaging tools, overcoming drug resistance, and improved treatment of metastasis are some examples of nanoparticle technology's increasing role. One of the limitations of conventional chemotherapy has been the toxic effects on normal cells by the chemotherapeutic agents limiting the dose. This limitation has been improved upon as targeted therapies have developed, and as nanoparticle technology has improved the selectivity of treatment. The development of a nano-robot that can autonomously detect cancerous cells, it has been constructed using engineered DNA strands that have been made to fold into a desired tertiary structure There have also been studies exploring the potential incorporation of Nano robots in tumor resection surgeries, to improve the detection and mapping of tumor margins intraoperatively. Nanotechnology has created the opportunity for numerous ways to improve oncology therapy and as nanorobotics technology progresses, it is doubtless that more applications will be envisioned. Further development of the existing technology towards the proposed designs has the potential to establish new standards in the treatment, screening, and prevention of cancer.